Frank Richard

461 total citations
17 papers, 372 citations indexed

About

Frank Richard is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Hematology. According to data from OpenAlex, Frank Richard has authored 17 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Hematology. Recurrent topics in Frank Richard's work include Asthma and respiratory diseases (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Frank Richard is often cited by papers focused on Asthma and respiratory diseases (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). Frank Richard collaborates with scholars based in Germany, United States and Switzerland. Frank Richard's co-authors include Anke Schwendel, Manfred Dietel, Iver Petersen, Udo-Michael Goehring, Franz Dürrenberger, Eric D. Bateman, Henrik Watz, Karsten Schlüns, Bernard Roubert and Klaus Winzer and has published in prestigious journals such as Blood, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Frank Richard

15 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Richard Germany 9 119 116 105 77 68 17 372
Xiaoran Huang China 9 45 0.4× 192 1.7× 139 1.3× 54 0.7× 32 0.5× 19 422
Hakim Ouled‐Haddou France 13 93 0.8× 116 1.0× 69 0.7× 34 0.4× 75 1.1× 30 357
Marién Pascual Spain 11 94 0.8× 270 2.3× 58 0.6× 49 0.6× 46 0.7× 18 408
Elizabeth Yang United States 11 51 0.4× 294 2.5× 45 0.4× 37 0.5× 128 1.9× 33 495
Piotr Łacina Poland 10 73 0.6× 203 1.8× 37 0.4× 76 1.0× 30 0.4× 26 368
Radhia M’kacher France 12 64 0.5× 183 1.6× 92 0.9× 121 1.6× 33 0.5× 28 410
Steve McCune United States 10 20 0.2× 85 0.7× 169 1.6× 79 1.0× 55 0.8× 16 326
Scott A. Peslak United States 12 78 0.7× 198 1.7× 29 0.3× 37 0.5× 174 2.6× 24 425
Beatriz Sánchez‐Espiridión United States 13 78 0.7× 225 1.9× 53 0.5× 140 1.8× 34 0.5× 18 475
Constantina Sambani Greece 15 20 0.2× 232 2.0× 55 0.5× 47 0.6× 89 1.3× 42 476

Countries citing papers authored by Frank Richard

Since Specialization
Citations

This map shows the geographic impact of Frank Richard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Richard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Richard more than expected).

Fields of papers citing papers by Frank Richard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Richard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Richard. The network helps show where Frank Richard may publish in the future.

Co-authorship network of co-authors of Frank Richard

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Richard. A scholar is included among the top collaborators of Frank Richard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Richard. Frank Richard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Orlowski, Robert Z., Shambavi Richard, Jonathan L. Kaufman, et al.. (2024). The Anti-BCMA Antibody-Drug Conjugate Hdp-101 with a Novel Amanitin Payload Shows Promising Initial First in Human Results in Relapsed Multiple Myeloma. Blood. 144(Supplement 1). 3381–3381.
2.
Garczarek, Ursula, et al.. (2022). Bayesian Strategies in Rare Diseases. Therapeutic Innovation & Regulatory Science. 57(3). 445–452. 4 indexed citations
3.
4.
Porter, John B., Alì Taher, Vip Viprakasit, et al.. (2021). Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development. Expert Review of Hematology. 14(7). 633–644. 15 indexed citations
5.
6.
Richard, Frank, et al.. (2019). Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers. American Journal of Hematology. 95(1). 68–77. 58 indexed citations
7.
Düngen, Hans‐Dirk, Lars Køber, Savina Nodari, et al.. (2018). Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction—Results of the CHIARA MIA 1 Trial. Clinical Pharmacology in Drug Development. 8(7). 942–951. 15 indexed citations
8.
Halpin, David, Claus Vogelmeier, Michael Pieper, et al.. (2016). Effect of tiotropium on COPD exacerbations: A systematic review. Respiratory Medicine. 114. 1–8. 16 indexed citations
9.
Miravitlles, Marc, et al.. (2016). A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. International Journal of COPD. 11. 407–407. 31 indexed citations
10.
Bateman, Eric D., Udo-Michael Goehring, Frank Richard, & Henrik Watz. (2016). Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma. Journal of Allergy and Clinical Immunology. 138(1). 142–149.e8. 44 indexed citations
11.
Calverley, Peter M.A., et al.. (2016). Tiotropium Respimat® Versus HandiHaler®: Comparison of Bronchodilator Efficacy of Various Doses in Clinical Trials. Advances in Therapy. 33(5). 786–793. 3 indexed citations
12.
Zheng, Jinping, Jinghua Yang, Xiangdong Zhou, et al.. (2013). Roflumilast for the Treatment of COPD in an Asian Population. CHEST Journal. 145(1). 44–52. 30 indexed citations
13.
Wiesinger, Herbert, Frank Richard, Dietmar Trummer, et al.. (2012). Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone. Clinical Drug Investigation. 32(10). 673–684. 3 indexed citations
14.
Blode, Hartmut, Christine Klipping, Frank Richard, et al.. (2011). Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone. Contraception. 85(2). 177–184. 5 indexed citations
15.
Richard, Frank, Manuela Pacyna‐Gengelbach, Karsten Schlüns, et al.. (2000). Patterns of chromosomal imbalances in invasive breast cancer. International Journal of Cancer. 89(3). 305–310.
16.
Richard, Frank, Manuela Pacyna-Gengelbach, Karsten Schlüns, et al.. (2000). Patterns of chromosomal imbalances in invasive breast cancer. International Journal of Cancer. 89(3). 305–310. 92 indexed citations
17.
Schwendel, Anke, Frank Richard, Holger Langreck, et al.. (1998). Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q. British Journal of Cancer. 78(6). 806–811. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoran Huang Breakdown of academic impact, for papers by Hakim Ouled‐Haddou Breakdown of academic impact, for papers by Marién Pascual Breakdown of academic impact, for papers by Elizabeth Yang Breakdown of academic impact, for papers by Piotr Łacina Breakdown of academic impact, for papers by Radhia M’kacher Breakdown of academic impact, for papers by Steve McCune Breakdown of academic impact, for papers by Scott A. Peslak Breakdown of academic impact, for papers by Beatriz Sánchez‐Espiridión Breakdown of academic impact, for papers by Constantina Sambani
Rankless by CCL
2026